OL
OnGen Ltd
The startup develops medical technology utilizing autologous transfer of bone marrow stem cells to treat autoimmune diseases, specifically targeting multiple sclerosis. This approach aims to enhance regenerative medicine outcomes by harnessing the body's own stem cells for effective disease management.
- Biotechnology
Updated 6 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops medical technology utilizing autologous transfer of bone marrow stem cells to treat autoimmune diseases, specifically targeting multiple sclerosis. This approach aims to enhance regenerative medicine outcomes by harnessing the body's own stem cells for effective disease management.